Beximco Pharmaceuticals, the local partner of Serum Institute of India (SII), on Monday assured that Bangladesh will get the agreed amount of vaccine doses on time as per agreement, reports UNB.
Quoting a communication with Beximco, an official said the statement made by Serum Institute, India (SII)on Sunday will not impact on the deal with Bangladesh.
Bangladesh is on a priority list as a result of prime minister Sheikh Hasina's diplomatic efforts, the official said.
Confusion arouse following a recent statement from Serum Institute, India (SII) whereby they stated that they will export the Oxford-Astrazeneca COVID-19 vaccine only after fulfilling their domestic demands in India.
Bangladesh has signed a deal with SII and Beximco for receiving 30 million doses of the said vaccine by the end of January or early February.
Foreign minister AK Abdul Momen is likely to talk to media on Monday where he is likely to address the issue.